HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats.

AbstractBACKGROUND:
Docosahexaenoic acid, a major omega-3 essential fatty acid family member, improves behavioral deficit and reduces infarct volume and edema after experimental focal cerebral ischemia. We hypothesize that DHA elicits neuroprotection by inducing AKT/p70S6K phosphorylation, which in turn leads to cell survival and protects against ischemic stroke in young and aged rats.
METHODS AND RESULTS:
Rats underwent 2 h of middle cerebral artery occlusion (MCAo). DHA, neuroprotectin D1 (NPD1) or vehicle (saline) was administered 3 h after onset of stroke. Neurological function was evaluated on days 1, 2, 3, and 7. DHA treatment improved functional recovery and reduced cortical, subcortical and total infarct volumes 7 days after stroke. DHA also reduced microglia infiltration and increased the number of astrocytes and neurons when compared to vehicle on days 1 and 7. Increases in p473 AKT and p308 AKT phosphorylation/activation were observed in animals treated with DHA 4 h after MCAo. Activation of other members of the AKT signaling pathway were also observed in DHA treated animals including increases in pS6 at 4 h and pGSK at 24 h. DHA or NPD1 remarkably reduced total and cortical infarct in aged rats. Moreover, we show that in young and aged rats DHA treatment after MCAo potentiates NPD1 biosynthesis. The phosphorylation of p308 AKT or pGSK was not different between groups in aged rats. However, pS6 expression was increased with DHA or NPD1 treatment when compared to vehicle.
CONCLUSIONS:
We suggest that DHA induces cell survival, modulates the neuroinflammatory response and triggers long term restoration of synaptic circuits. Both DHA and NPD1 elicited remarkable protection in aged animals. Accordingly, activation of DHA signaling might provide benefits in the management of ischemic stroke both acutely as well as long term to limit ensuing disabilities.
AuthorsTiffany N Eady, Ludmila Belayev, Larissa Khoutorova, Kristal D Atkins, Changde Zhang, Nicolas G Bazan
JournalPloS one (PLoS One) Vol. 7 Issue 10 Pg. e46151 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID23118851 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • protectin D1
  • Docosahexaenoic Acids
  • Proto-Oncogene Proteins c-akt
Topics
  • Animals
  • Behavior (drug effects)
  • Brain Ischemia (metabolism, pathology, therapy)
  • Cell Survival (drug effects)
  • Disease Models, Animal
  • Docosahexaenoic Acids (administration & dosage, biosynthesis)
  • Gene Expression Regulation (drug effects)
  • Humans
  • Infarction, Middle Cerebral Artery
  • Male
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats
  • Recovery of Function (drug effects)
  • Signal Transduction
  • Stroke (metabolism, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: